FDA Inspection 1151614 — Thierry Brue, M.D., Ph.D
The FDA completed an inspection of Thierry Brue, M.D., Ph.D on September 10, 2021 in Marseille, CEDEX 05. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 10, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Marseille, CEDEX 05 (France)
Additional Details
Clinical Investigator (CI)